Sunflower Capital Research
Investment Thesis
Sunflower Capital is a seed-stage venture capital firm that partners at the earliest stage with companies building the foundations for modern enterprises, critical industries, and the physical world. The firm was founded by Liu Jiang, a former partner at Sequoia Capital who spent nearly a decade investing in early-stage enterprise software before starting Sunflower. Sunflower explicitly backs what it calls "N-of-1 companies" - category-defining teams that create new markets or transform legacy industries by combining defensible technology with novel go-to-market approaches. The firm positions itself as leading with empathy and respecting the founder journey, often writing the first check before a product even exists.
Note on the provided URL: The website supplied for this research, sunflower.capital, is a parked/expired domain now listed for sale on GoDaddy and does not belong to the firm. The firm's actual live website is sunflowercapital.co. This research was conducted against the correct domain, and the firm record's website/domain fields have been corrected accordingly.
Sector Focus
Sunflower invests across a deliberately broad set of technical sectors rather than a single vertical:
- AI & Applied Compute
- Developer Tools & Infrastructure
- Healthcare & Biotech
- Defense & Hardware
- Data & Analytics
- SaaS & Go-to-Market
- Security
- Robotics
- Fintech & Crypto
The throughline across sectors is technical defensibility: infrastructure-layer, data-layer, or hard-tech companies rather than pure consumer or lightly-differentiated SaaS.
Stage Focus
Sunflower focuses on pre-seed, seed, seed-extension ("seed+"), and selectively Series A. They aim to be the first institutional check, before initial product development is complete, and remain closely involved as advisors through pivotal early moments (first hires, first enterprise customers, follow-on fundraises).
Check Size
Initial checks typically range from $1M-$3M. Notably, Fund II deploys 100% of committed capital into initial checks with no reserve held back for follow-ons - a deliberate structural choice to maximize capital available to found-stage founders rather than protecting ownership in winners via reserves.
Recent Activity
Sunflower Capital closed Fund II at $150M in roughly one month in April 2025, bringing combined AUM across Fund I and Fund II to approximately $250M (publicly announced May 14, 2025). LPs in Fund II include Dana-Farber Cancer Institute, Children's Health, California State Teachers' Retirement System (via Sapphire Partners), Pathstone, Industry Ventures, and Screendoor - an unusually institutional LP base for a firm this early-stage.
The firm remains actively deploying: in March 2026 Sunflower participated (alongside BoxGroup and notable fintech/crypto angels) in a16z crypto's $10M seed round for The Better Money Company, a stablecoin clearinghouse.
Portfolio Highlights
Sunflower's portfolio spans 60+ companies. Notable names include Cohere (foundation models), Vercel (Next.js/frontend infra), Retool (internal tools), Warp (terminal), PostHog (product analytics), Statsig (experimentation), dbt Labs (data transformation), Temporal (durable execution), Railway (deployment infra), Deel (global payroll/EOR), Verkada (physical security/cameras), Hadrian (defense manufacturing), Commure (healthcare infrastructure), Semgrep (static analysis security), Clay (GTM data), E2B (AI code sandboxes), Ollama (local LLM runtime), and Roboflow (computer vision tooling). Several portfolio companies (Cohere, Vercel, Deel, Verkada) have since become well-known, multi-hundred-million-to-billion-dollar outcomes, lending credibility to the firm's stated thesis of picking category-defining infrastructure and hard-tech bets pre-product.
Team
- Liu Jiang, Founder & Managing Partner - Former partner at Sequoia Capital, where he spent nearly a decade investing in early-stage enterprise software. Founded Sunflower to focus exclusively on the earliest, pre-product stage of company formation.
- Max Wang, Partner - Focuses on SaaS and fintech investments.
- Mo Punjwani, Partner - Focuses on healthcare and biotech investments.
The partnership is small and hands-on (a team of roughly three investing partners across $250M in combined AUM), consistent with the firm's high-touch, advisor-through-pivotal-moments positioning.
Decision Process
Sunflower operates as a small partnership (Liu Jiang, Max Wang, Mo Punjwani) rather than a solo-GP shop or a large investment committee. Founders can apply directly through the firm's website; warm introductions are preferred but explicitly not required. The firm aims to respond within a few weeks depending on submission volume, and emphasizes clear, concise pitch materials.
Founder Preferences
Sunflower's public materials emphasize backing technical, category-defining teams willing to build defensible technology married to a novel go-to-market motion, often before there is a finished product. The firm's language ('N-of-1 companies,' 'respecting the founder journey') suggests a preference for conviction-stage bets on unusually differentiated technical founders over pattern-matched, crowded-category teams.
Geographic Focus
Headquartered in West Hollywood, CA (Los Angeles area), with a primary focus on U.S.-based companies, though the portfolio includes globally-operating companies (e.g., Deel). No indication of a hard geographic restriction beyond a general U.S. center of gravity.